EC Healthcare Signs Sustainability-Linked Syndicated Facility, A Ground-breaking Achievement in Hong Kong Healthcare Industry May 10, 2023 11:52 HKT | |
|
Avance Clinical CEO Joins Global BioPharma Panel for Evolution Europe Summit 2023 Apr 18, 2023 11:00 HKT | |
|
HanchorBio Announces US IND Clearance for the Multi-Regional Clinical Trial of HCB101 to Treat Solid and Hematological Malignancies Apr 17, 2023 19:30 HKT | |
|
Essex and Osteopore Entered into Exclusive Distribution Agreement for Oral Maxillofacial products in Singapore Apr 14, 2023 17:18 HKT | |
|
Essex and Gunze Shenzhen Entered into Exclusive Agency Agreement for PELNAC Absorbable Dressing in Mainland China Apr 11, 2023 12:58 HKT | |
|
TrialWire Patient Recruitment Platform Launches AI Pre-recruit to Cut Recruitment Time by 50% Apr 11, 2023 08:00 HKT | |
|
Apollomics, a Company Developing Novel Oncology Therapies to Address Difficult-to-Treat Cancers, Announces Closing of Business Combination and Listing on Nasdaq Mar 30, 2023 20:29 HKT | |
|
Singapore family cord blood bank Cryoviva upgrades to AXP II System for cord blood processing Mar 21, 2023 08:30 HKT | |
|
Essex Bio-Technology Announces 2022 Annual Financial Results Mar 08, 2023 20:28 HKT | |
|
Essex and Henlius signed amendment agreement for Global Co-Development and Exclusive License Agreement for treatment of age-related macular degeneration Feb 22, 2023 18:48 HKT | |
|
The Evolving Global Landscape in Vaccine Development: Novotech and Endpoints News Webinar Feb 15, 2023 09:00 HKT | |
|
First Patient in the US Dosed in a Global Multicentre Phase 3 Clinical Study of Bevacizumab for treatment of Ophthalmic Diseases Feb 10, 2023 21:06 HKT | |
|
Novotech Global Report: Robust Phase 1 Trial Growth Across Asia Pacific Feb 10, 2023 19:00 HKT | |
|
Asia Pacific Cell & Gene Research Growing 50% Faster than ROW Feb 03, 2023 13:00 HKT | |
|
Novotech Acquires US-based Drug Development Consulting Firm, CBR International Jan 12, 2023 15:00 HKT | |
|
Novotech Acquires European CRO, Strengthens Global Operations Jan 12, 2023 15:00 HKT | |
|
HighTide Therapeutics Announces First Patient Dosed in Phase 2b Clinical Study Evaluating HTD1801 in NASH (the CENTRICITY study) Jan 11, 2023 21:00 HKT | |
|
Avance Clinical Celebrates GlobalReady Success as 40 Biotechs Join Program Jan 11, 2023 15:00 HKT | |
|
HighTide Therapeutics Raises $107 Million in Series C/C+ Financing to Advance Innovative Pipeline and Business Collaborations Jan 05, 2023 18:00 HKT | |
|
Novotech is Gold Sponsor at Biotech Showcase 2023 Dec 20, 2022 11:00 HKT | |
|